Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Clinical trial NCT02480114 · COMPLETED

Trial details

NCT number: NCT02480114
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Head and Neck Neoplasm Mucositis Radiation-Induced Disorder

Start date: 2015-07-01
Primary completion: 2019-09-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.